Envestnet Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,911
| Closed | -$289K | – | 4329 |
|
|
2023
Q4 | $289K | Sell |
4,911
-77,502
| -94% | -$4.55M | ﹤0.01% | 3644 |
|
|
2023
Q3 | $3.59M | Buy |
82,413
+59,968
| +267% | +$2.61M | ﹤0.01% | 2019 |
|
|
2023
Q2 | $811K | Buy |
22,445
+2,502
| +13% | +$90.4K | ﹤0.01% | 2899 |
|
|
2023
Q1 | $741K | Buy |
19,943
+3,325
| +20% | +$124K | ﹤0.01% | 2877 |
|
|
2022
Q4 | $753K | Buy |
16,618
+1,419
| +9% | +$64.3K | ﹤0.01% | 2845 |
|
|
2022
Q3 | $1.06M | Buy |
15,199
+1,075
| +8% | +$75K | ﹤0.01% | 2524 |
|
|
2022
Q2 | $948K | Buy |
14,124
+6,056
| +75% | +$406K | ﹤0.01% | 2638 |
|
|
2022
Q1 | $663K | Buy |
+8,068
| New | +$663K | ﹤0.01% | 2954 |
|
|
2021
Q4 | – | Sell |
-1,213
| Closed | -$215K | – | 3966 |
|
|
2021
Q3 | $215K | Buy |
+1,213
| New | +$215K | ﹤0.01% | 3472 |
|
|
2021
Q2 | – | Sell |
-1,593
| Closed | -$273K | – | 3715 |
|
|
2021
Q1 | $273K | Buy |
1,593
+219
| +16% | +$37.5K | ﹤0.01% | 3188 |
|
|
2020
Q4 | $302K | Sell |
1,374
-552
| -29% | -$121K | ﹤0.01% | 2924 |
|
|
2020
Q3 | $320K | Buy |
+1,926
| New | +$320K | ﹤0.01% | 2702 |
|